|
Volumn 24, Issue 10, 2005, Pages 1252-1256
|
Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HERBACEOUS AGENT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CHINESE MEDICINE;
CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PHYTOTHERAPY;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
COMBINED MODALITY THERAPY;
DRUGS, CHINESE HERBAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LUNG NEOPLASMS;
MALE;
MEDICINE, CHINESE TRADITIONAL;
MIDDLE AGED;
NEOPLASM STAGING;
PHYTOTHERAPY;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
PROSPECTIVE STUDIES;
|
EID: 34548534930
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|